Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
824.00    -2.00 (-0.24%)
Bid:
824.00
Ask:
826.00
Spread: 2.00 (0.243%)
Market Cap: £8.24b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Total Voting Rights

1 Jul 2024 07:00

RNS Number : 4425U
Wise PLC
01 July 2024
 

 

 Wise plc

(the "Company")

 

Total Voting Rights and Capital

 

In accordance with Disclosure Guidance and Transparency Rule 5.6.1 the Company would like to notify the market of the following:

The Company's issued share capital consists of 1,024,777,252 class A ordinary shares of £0.01, each carrying one vote ("Class A Shares") and 398,889,814 class B ordinary shares of £0.000000001. The Company does not hold any Class A Shares or Class B Shares in treasury.

The total number of voting rights attributable to the Class A Shares is 1,024,777,252.

Further to a cessation of voting rights in respect of 8,000,000 Class B Shares (carrying, in aggregate, 72,000,000 voting rights) on 14 June 2024, in accordance with the Company's articles of association, the total number of voting rights attributable to the Class B Shares is 2,193,435,144 and therefore the total number of voting rights in the Company in aggregate across the Class A Shares and the Class B Shares is 3,218,212,396.

It is noted that the latest aggregate voting rights in the Company across the Class A Shares and the Class B Shares would result in Kristo Käärmann holding over 50% of the total voting rights in the Company through his Class A Share and Class B Share holding. In accordance with the Company's articles of association, for so long as Kristo Käärmann remains Chief Executive Officer of the Company, his voting rights are capped by reducing the exercisable votes in respect of his Class B Share holding to one vote below 50% of the total votes eligible to be cast in respect of a shareholder resolution (reducing to one vote below 35% should he cease to be Chief Executive Officer of the Company).

When accounting for the total number of Class B Share voting rights that will be restricted as a result of the above-mentioned cap, the total exercisable voting rights in the Company in respect of the Class B Shares is 1,934,461,882 meaning that the total exercisable voting rights in the Company in aggregate across the Class A Shares and Class B Shares is 2,959,239,134.

For any queries related to this, please contact the Company Secretariat on cosec@wise.com

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRKZGZVKRVGDZM
Date   Source Headline
3rd Jun 20264:25 pmRNSHolding(s) in Company
2nd Jun 202611:44 amRNSTotal Voting Rights
1st Jun 20268:59 amRNSWise Europe
11th May 202611:00 amRNSWise debuts US listing on Nasdaq
11th May 20268:00 amRNSTotal Voting Rights
11th May 20268:00 amRNSCancellation - Wise plc
11th May 20267:00 amRNSScheme of Arrangement becomes effective
6th May 202612:43 pmRNSDirector/PDMR Shareholding
1st May 20261:55 pmRNSTotal Voting Rights
27th Apr 20263:33 pmRNSScheme of Arrangement
24th Apr 20261:07 pmRNSDirector/PDMR Shareholding
23rd Apr 20262:49 pmRNSTotal Voting Rights
22nd Apr 20263:13 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:32 pmRNSHolding(s) in Company
16th Apr 20264:01 pmRNSDirector/PDMR Shareholding
13th Apr 20261:39 pmRNSPublication of a Prospectus
13th Apr 20267:53 amRNSQ4 FY2026 Trading Update
13th Apr 20267:01 amRNSTranslation of IFRS financials into US GAAP
13th Apr 20267:00 amRNSQ4 FY2026 Trading Update
9th Apr 20269:05 amRNSNotice of Q4 FY2026 Results
1st Apr 20262:50 pmRNSTotal Voting Rights
3rd Mar 202610:46 amRNSTotal Voting Rights
2nd Mar 20269:00 amRNSBoard Appointment
16th Feb 202610:43 amRNSChange of Adviser
4th Feb 202612:54 pmRNSHolding(s) in Company
2nd Feb 20264:13 pmRNSTotal Voting Rights
30th Jan 20263:43 pmRNSHolding(s) in Company
23rd Jan 202612:02 pmRNSDirector/PDMR Shareholding
20th Jan 20264:15 pmRNSDirector/PDMR Shareholding
20th Jan 20267:00 amRNSWise Q3 FY26 trading update
19th Jan 20263:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20261:11 pmRNSTotal Voting Rights
3rd Dec 202512:53 pmRNSDirector/PDMR Shareholding
1st Dec 20252:57 pmRNSTotal Voting Rights
21st Nov 202512:35 pmRNSPublication of pricing supplements
18th Nov 20255:00 pmRNSDirector/PDMR Shareholding
13th Nov 20259:14 amRNSEstablishment of Euro Medium Term Note Programme
10th Nov 202510:28 amRNSDirector/PDMR Shareholding
7th Nov 20253:24 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSFY26 Half Year Results
3rd Nov 20254:35 pmRNSTotal Voting Rights
16th Oct 20255:20 pmRNSDirector/PDMR Shareholding
10th Oct 20251:46 pmRNSTotal Voting Rights
9th Oct 20252:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20253:36 pmRNSDirector/PDMR Shareholding
25th Sep 20253:31 pmRNSResult of AGM
23rd Sep 20253:40 pmRNSHolding(s) in Company
23rd Sep 20252:03 pmRNSTotal Voting Rights
9th Sep 20255:56 pmRNSDirector/PDMR Shareholding
1st Sep 20252:13 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.